Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001390202-26-000013
Filing Date
2026-08-04
Accepted
2026-08-04 17:48:48
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10575
  Complete submission text file 0001390202-26-000013.txt   12392
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88651 | Film No.: 261240485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017
Business Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017 212-938-6325
Laurion Capital Management LP (Filed by) CIK: 0001390202 (see all company filings)

EIN.: 562504425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G